The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Synaptic dysregulation in a human iPS cell model of mental disorders
Open accessAbstract
Dysregulated neurodevelopment with altered structural and functional connectivity is believed to underlie many neuropsychiatric disorders, and 'a disease of synapses' is the major hypothesis for the biological basis of schizophrenia. Although this hypothesis has gained indirect support from human post-mortem brain analyses and genetic studies, little is known about the pathophysiology of synapses in patient neurons and how susceptibility genes for mental disorders could lead to synaptic deficits in humans. Genetics of most psychiatric disorders are extremely complex due to multiple susceptibility variants with low penetrance and variable phenotypes. Rare, multiply affected, large families in which a single genetic locus is probably responsible for conferring susceptibility have proven invaluable for the study of complex disorders. Here we generated induced pluripotent stem (iPS) cells from four members of a family in which a frameshift mutation of disrupted in schizophrenia 1 (DISC1) co-segregated with major psychiatric disorders and we further produced different isogenic iPS cell lines via gene editing. We showed that mutant DISC1 causes synaptic vesicle release deficits in iPS-cell-derived forebrain neurons. Mutant DISC1 depletes wild-type DISC1 protein and, furthermore, dysregulates expression of many genes related to synapses and psychiatric disorders in human forebrain neurons. Our study reveals that a psychiatric disorder relevant mutation causes synapse deficits and transcriptional dysregulation in human neurons and our findings provide new insight into the molecular and synaptic etiopathology of psychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“SV2, a marker for mature synaptic vesicles and regulates presynaptic release (70, 71)”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
RSeQC: quality control of RNA-seq experiments
Wang, L., Wang, S., & Li, W. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts356 · Cited by 2,753
Čermák, T., Doyle, E., Christian, M. L., Wang, L., Zhang, Y., Schmidt, C. L., Baller, J. A., Somia, N. V., Bogdanove, A. J., & Voytas, D. F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr218 · Cited by 2,034
De novo mutations in schizophrenia implicate synaptic networks
Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., et al. (2014) · Nature · doi:10.1038/nature12929 · Cited by 1,617
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013
Wang, J., Duncan, D. T., Shi, Z., & Zhang, B. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt439 · Cited by 1,512
A polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385
Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375
Self-citation
Cited by
Sorted by citations
Items 101–200 of 551
Expression-based drug screening of neural progenitor cells from individuals with schizophrenia
Readhead, B. P., Hartley, B. J., Eastwood, B. J., Collier, D. A., Evans, D. A. P., Farias, R., He, C., Hoffman, G. E., Sklar, P. B., Dudley, J. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06515-4 · Cited by 76
Modeling neuropsychiatric disorders using human induced pluripotent stem cells
Wang, M., Zhang, L., & Gage, F. H. (2019) · Protein & Cell · doi:10.1007/s13238-019-0638-8 · Cited by 76
Hammack, C., Ogden, S. C., Madden, J. C., Medina, A., Xu, C., Phillips, E. O. N., Son, Y., Cone, A. S., Giovinazzi, S., Didier, R., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00638-19 · Cited by 73
Self-citationDownregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia
Chadha, R., & Meador‐Woodruff, J. H. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0614-2 · Cited by 74
Prediction of treatment outcomes in psychiatry—where do we stand ?
McMahon, F. J. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/fmcmahon · Cited by 72
de Vrij, F. M. S., Bouwkamp, C. G., Gunhanlar, N., Shpak, G., Lendemeijer, B., Baghdadi, M., Gopalakrishna, S., Ghazvini, M., Li, T. M. W. Y., Quadri, M., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-017-0004-2 · Cited by 71
Synaptic dysfunction in complex psychiatric disorders: from genetics to mechanisms
Wang, X., Christian, K. M., Song, H., & Ming, G.-L. (2018) · Genome Medicine · doi:10.1186/s13073-018-0518-5 · Cited by 71
Self-citationGrobarczyk, B., Franco, B., Hanon, K., & Malgrange, B. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9600-1 · Cited by 71
Chen, J., Zang, Z., Braun, U., Schwarz, K., Harneit, A., Kremer, T., Ma, R., Schweiger, J., Moessnang, C., Geiger, L., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.4792 · Cited by 69
Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies
McTague, A., Rossignoli, G., Ferrini, A., Barral, S., & Kurian, M. A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.630600 · Cited by 67
Bradshaw, N. J., & Korth, C. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0133-2 · Cited by 66
New considerations for hiPSC-based models of neuropsychiatric disorders
Hoffman, G. E., Schrode, N., Flaherty, E. K., & Brennand, K. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0029-1 · Cited by 71
Page, S. C., Sripathy, S. R., Farinelli, F., Ye, Z., Wang, Y., Hiler, D. J., Pattie, E. A., Nguyen, C. V., Tippani, M., Moses, R. L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109395119 · Cited by 62
Wang, W., Jia, Y., Pham, D. T., Palmer, L. C., Jung, K., Cox, C. D., Rumbaugh, G., Piomelli, D., Gall, C. M., & LYNCH, G. S. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx126 · Cited by 65
Pluripotent stem cell-based disease modeling: current hurdles and future promise
Zeltner, N., & Studer, L. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.10.008 · Cited by 68
Kumar, A., Karuppagounder, S. S., Chen, Y., Corona, C., Kawaguchi, R., Cheng, Y., Balkaya, M., Sagdullaev, B. T., Wen, Z., Stuart, C., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.06.013 · Cited by 64
Self-citationNarla, S. T., Lee, Y. W., Benson, C. A., Sarder, P., Brennand, K., Stachowiak, E. K., & Stachowiak, M. K. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2016.12.012 · Cited by 61
Kuehner, J. N., Chen, J., Bruggeman, E. C., Wang, F., Li, Y., Xu, C., McEachin, Z. T., Li, Z., Chen, L., Hales, C. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109042 · Cited by 60
Self-citationOn the Teneurin track: a new synaptic organization molecule emerges
Mosca, T. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00204 · Cited by 61
Gokhale, A., Hartwig, C. L., Freeman, A. A. H., Bassell‐Hawkins, J., Zlatic, S. A., Savas, C. S., Vadlamudi, T., Abudulai, F., Pham, T. T., Crocker, A. J., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1983-18.2019 · Cited by 61
Self-citationDepressive patient‐derived GABA interneurons reveal abnormal neural activity associated with HTR2C
Lu, K., Hong, Y., Tao, M., Shen, L., Zheng, Z., Fang, K.-H., Yuan, F., Xu, M., Wang, C., Zhu, D., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216364 · Cited by 59
Corti, S. P., Faravelli, I., Cardano, M., & Conti, L. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1037737 · Cited by 65
Genetics of Schizophrenia: Ready to Translate?
Foley, C., Corvin, A. P., & Nakagome, S. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0807-5 · Cited by 61
A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases
Topol, A., Tran, N. N., & Brennand, K. J. (2015) · Journal of Visualized Experiments · doi:10.3791/52495 · Cited by 58
Tau pathology epigenetically remodels the neuron-glial cross-talk in Alzheimer’s disease
Zhou, L., Liu, D., Kang, H., Lu, L., Huang, H., Ai, W.-Q., Zhou, Y., Deng, M., Li, H., Liu, Z., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq7105 · Cited by 58
Self-citationLocal-to-remote cortical connectivity in early- and adulthood-onset schizophrenia
Jiang, L., Xu, Y., Zhu, X.-T., Yang, Z., Hj, L., & Zuo, X. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.59 · Cited by 55
Wang, Q., Lu, Q., & Zhao, H. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00149 · Cited by 62
Precocious neuronal differentiation and disrupted oxygen responses in Kabuki syndrome
Carosso, G. A., Boukas, L., Augustin, J. J., Nguyen, H. N., Winer, B. L., Cannon, G. H., Robertson, J. D., Zhang, L., Hansen, K. D., Goff, L. A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129375 · Cited by 57
Self-citationNi, C., Jiang, W., Wang, Z., Wang, Z., Zhang, J., Zheng, X., Liu, Z., Ou, H., Jiang, T., Liang, W., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0662-3 · Cited by 58
Self-citationTopol, A., English, J. A., Flaherty, E. K., Rajarajan, P., Hartley, B. J., Gupta, S., Desland, F. A., Zhu, S., Goff, T., Friedman, L., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.118 · Cited by 57
Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models
Haggarty, S. J., Silva, M. C., Cross, A. J., Brandon, N. J., & Perlis, R. H. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.01.011 · Cited by 57
Onwordi, E. C., Whitehurst, T., Mansur, A., Statton, B., Berry, A., Quinlan, M., O’Regan, D. P., Rogdaki, M., Marques, T. R., Rabiner, E. A., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01515-3 · Cited by 55
Modeling Brain Disorders Using Induced Pluripotent Stem CellsPreprint
Vadodaria, K. C., Jones, J. R., Linker, S. B., & Gage, F. H. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a035659 · Cited by 52
Kim, B. W., Ryu, J., Jeong, Y. E., Kim, J., & Martin, L. J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.604171 · Cited by 53
Single-cell RNA-seq reveals dynamic transcriptome profiling in human early neural differentiation
Shang, Z., Chen, D., Wang, Q., Wang, S., Deng, Q., Wu, L. L., Liu, C., Ding, X., Wang, S., Zhong, J., et al. (2018) · GigaScience · doi:10.1093/gigascience/giy117 · Cited by 51
Nakazawa, T., Kikuchi, M., Ishikawa, M., Yamamori, H., Nagayasu, K., Matsumoto, T., Fujimoto, M., Yasuda, Y., Fujiwara, M., Okada, S., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.10.012 · Cited by 49
Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia
Bentea, E., DePasquale, E. A. K., O'Donovan, S. M., Sullivan, C. R., Simmons, M. S., Meador‐Woodruff, J. H., Zhou, Y., Xu, C., Bai, B., Peng, J., et al. (2019) · Molecular Omics · doi:10.1039/c8mo00173a · Cited by 46
Self-citationGrunwald, L.-M., Breitmeyer, R., Haag, K., Buckenmaier, S., Eberle, M.-C., Wildgruber, D., Storchak, H., Kriebel, M., Weißgraeber, S., Mathew, L. A., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0517-3 · Cited by 55
Probing disorders of the nervous system using reprogramming approaches
Ichida, J. K., & Kiskinis, E. (2015) · The EMBO Journal · doi:10.15252/embj.201591267 · Cited by 51
Ohgidani, M., Kato, T. A., & Kanba, S. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00184 · Cited by 52
The iPSC perspective on schizophrenia
Räsänen, N., Tiihonen, J., Koskuvi, M., Lehtonen, Š., & Koıstınaho, J. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.11.002 · Cited by 56
Modeling Psychiatric Disorder Biology with Stem Cells
Das, D., Feuer, K. L., Wahbeh, M. H., & Avramopoulos, D. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01148-1 · Cited by 49
Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease
Vu, M., Li, R., Baskfield, A., Lu, B., Farkhondeh, A., Gorshkov, K., Motabar, O., Beers, J. K., Chen, G.-K., Zou, J., et al. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0886-3 · Cited by 42
Self-citationHuman IPSC-Derived Model to Study Myelin Disruption
Chesnut, M., Paschoud, H., Repond, C., Smirnova, L., Härtung, T., Zurich, M., Högberg, H. T., & Pamies, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179473 · Cited by 56
Advancing preclinical models of psychiatric disorders with human brain organoid cultures
Dixon, T. A., & Muotri, A. R. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01708-2 · Cited by 49
Schulmann, A., Ryu, E., Gonçalves, V. F., Rollins, B. L., Christiansen, M., Frye, M. A., Biernacka, J. M., & Vawter, M. P. (2019) · Complex Psychiatry · doi:10.1159/000495658 · Cited by 48
Connectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel Treatments
Sullivan, C. R., Mielnik, C. A., O'Donovan, S. M., Funk, A. J., Bentea, E., DePasquale, E. A. K., Alganem, K., Wen, Z., Haroutunian, V. H., Katsel, P., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1390-4 · Cited by 48
Self-citationNeuroserpin: structure, function, physiology and pathology
D’Acunto, E., Fra, A., Visentin, C., Manno, M., Ricagno, S., Galliciotti, G., & Miranda, E. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03907-6 · Cited by 48
Jiang, X., Detera‐Wadleigh, S. D., Akula, N., Mallon, B. S., Hou, L., Xiao, T., Felsenfeld, G., Gu, X., & McMahon, F. J. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0207-1 · Cited by 47
Targeting Hsc70-based autophagy to eliminate amyloid β oligomers
Dou, J., Su, P., Xu, C., Wen, Z., Mao, Z., & Li, W. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.016 · Cited by 46
Self-citationSchnellmann, R., Ntekoumes, D., Choudhury, M. I., Sun, S. X., Zhao, W., & Gerecht, S. (2022) · Advanced Science · doi:10.1002/advs.202201483 · Cited by 45
Serotonin in psychiatry: in vitro disease modeling using patient-derived neurons
Vadodaria, K. C., Stern, S., Marchetto, M. C., & Gage, F. H. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2670-4 · Cited by 44
Zhang, F., Yoon, K., Zhang, D. Y., Kim, N., Ming, G., & Song, H. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.01.007 · Cited by 43
Self-citationCho, H., Macklin, B. L., Lin, Y.-Y., Zhou, L., Lai, M. J., Lee, G., Gerecht, S., & Duh, E. J. (2020) · JCI Insight · doi:10.1172/jci.insight.131828 · Cited by 43
Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7
Sato‐Kasai, M., Kato, T. A., Ohgidani, M., Mizoguchi, Y., Sagata, N., Inamine, S., Horikawa, H., Hayakawa, K., Shimokawa, N., Kyuragi, S., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.08.022 · Cited by 46
Johnstone, M., Vasistha, N. A., Barbu, M. C., Dando, O., Burr, K., Christopher, E., Glen, S., Robert, C., Fetit, R., MacLeod, K. G., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0292-1 · Cited by 43
Wang, X., Ye, F., Wen, Z.-X., Guo, Z., Yu, C., Huang, W.-K., Ringeling, F. R., Su, Y.-J., Zheng, W., Zhou, G.-Q., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0485-2 · Cited by 41
Self-citationPharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutation
Kim, N.-S., Wen, Z., Liu, J., Zhou, Y., Guo, Z., Xu, C., Lin, Y.-T., Yoon, K., Park, J., Cho, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21713-3 · Cited by 41
Self-citationBeekhuis-Hoekstra, S. D., Stringer, S., Heine, V. M., & Posthuma, D. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00164 · Cited by 42
Induced Pluripotent Stem Cells in Disease Modeling and Gene Identification
Kumar, S., Blangero, J., & Curran, J. E. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7471-9_2 · Cited by 41
Cell-Based Screening: Extracting Meaning from Complex Data
Finkbeiner, S. M., Frumkin, M. A., & Kassner, P. D. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.023 · Cited by 40
Watmuff, B., Berkovitch, S. S., Huang, J., Iaconelli, J., Toffel, S., & Karmacharya, R. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.01.003 · Cited by 40
Rutkowski, T. P., Schroeder, J. P., Gafford, G. M., Warren, S. T., Weinshenker, D., Caspary, T., & Mullé, J. G. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23970 · Cited by 40
Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders
Schadt, E. E., Buchanan, S., Brennand, K. J., & Merchant, K. M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00252 · Cited by 39
Cheng, C., Fass, D. M., Folz‐Donahue, K., MacDonald, M. E., & Haggarty, S. J. (2017) · Current Protocols in Human Genetics · doi:10.1002/cphg.33 · Cited by 39
Tomaskovic‐Crook, E., Gu, Q., Rahim, S. N. A., Wallace, G. G., & Crook, J. M. (2020) · Cells · doi:10.3390/cells9030658 · Cited by 39
Screening for modulators of neural network activity in 3D human iPSC-derived cortical spheroids
Woodruff, G., Phillips, N., Carromeu, C., Guicherit, O. M., White, A., Johnson, M., Zanella, F., Anson, B. D., Lovenberg, T. W., Bonaventure, P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240991 · Cited by 40
Long-term exposure to cadmium disrupts neurodevelopment in mature cerebral organoids
Huang, Y., Guo, X., Lu, S., Chen, Q., Wang, Z., Lai, L., Liu, Q., Zhu, X., Luo, L., Li, J., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.168923 · Cited by 39
Dawson, N., Kurihara, M., Thomson, D. M., Winchester, C. L., McVie, A., Hedde, J. R., Randall, A. D., Shen, S., Seymour, P. A., Hughes, Z. A., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.60 · Cited by 39
Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity
Pamies, D., Wiersma, D., Katt, M. E., Zhao, L., Burtscher, J., Harris, G., Smirnova, L., Searson, P. C., Härtung, T., & Högberg, H. T. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105719 · Cited by 39
Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications
Chang, C.-Y., Ting, H.-C., Su, H., & Jeng, J. (2018) · Cell Transplantation · doi:10.1177/0963689718754560 · Cited by 39
FBXW7 regulates DISC1 stability via the ubiquitin-proteosome system
Yalla, K., Elliott, C., Day, J., Findlay, J., Barratt, S., Hughes, Z., Wilson, L., Whiteley, E., Popiolek, M., Li, Y., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.138 · Cited by 34
Reumann, R., Vierk, R., Zhou, L., Gries, F., Kraus, V., Mienert, J., Romswinkel, E. V., Morellini, F., Ferrer, I., Nicolini, C., et al. (2017) · Learning & Memory · doi:10.1101/lm.045864.117 · Cited by 38
Publicly Available hiPSC Lines with Extreme Polygenic Risk Scores for Modeling Schizophrenia
Dobrindt, K., Zhang, H., Das, D., Abdollahi, S., Prorok, T., Ghosh, S. D., Weintraub, S. J., Genovese, G., Powell, S. K., Lund, A. N., et al. (2020) · Complex Psychiatry · doi:10.1159/000512716 · Cited by 32
Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies
Nestor, M. W., Phillips, A. W., Artimovich, E., Nestor, J. E., Hussman, J. P., & Blatt, G. J. (2015) · Autism Research · doi:10.1002/aur.1570 · Cited by 36
PCM1 is necessary for focal ciliary integrity and is a candidate for severe schizophrenia
Monroe, T. O., Garrett, M. E., Kousi, M., Rodriguiz, R. M., Moon, S., Bai, Y., Brodar, C., Soldano, K. L., Savage, J. H., Hansen, T. F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19637-5 · Cited by 35
Increased nicotine response in iPSC-derived human neurons carrying the CHRNA5 N398 allele
Oni, E. N., Halikere, A., Li, G., Toro-Ramos, A. J., Swerdel, M. R., Verpeut, J. L., Moore, J. C., Bello, N. T., Bierut, L. J., Goate, A., et al. (2016) · Scientific Reports · doi:10.1038/srep34341 · Cited by 32
In VivoImaging of CNS Injury and Disease
Akassoglou, K., Merlini, M., Rafalski, V. A., Real, R., Liang, L., Jin, Y., Dougherty, S. E., Paola, V. D., Linden, D. J., Misgeld, T., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1826-17.2017 · Cited by 33
Wilkinson, B., Evgrafov, O., Zheng, D.-Q., Hartel, N. G., Knowles, J., Graham, N., Ichida, J., & Coba, M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.05.009 · Cited by 29
Smith, Q., Macklin, B. L., Chan, X. Y., Jones, H., Trempel, M. A., Yöder, M. C., & Gerecht, S. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.083 · Cited by 34
Nanoscale synapse organization and dysfunction in neurodevelopmental disorders
Zieger, H. L., & Choquet, D. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105453 · Cited by 35
Regulation of synaptic connectivity in schizophrenia spectrum by mutual neuron-microglia interaction
Breitmeyer, R., Vogel, S., Heider, J., Hartmann, S.-M., Wüst, R., Keller, A., Binner, A., Fitzgerald, J. C., Fallgatter, A. J., & Volkmer, H. (2023) · Communications Biology · doi:10.1038/s42003-023-04852-9 · Cited by 36
Chatzidaki, A., Fouillet, A., Li, J., Dage, J. L., Millar, N. S., Sher, E., & Ursu, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125116 · Cited by 33
Differentiation of pluripotent stem cells for regenerative medicine
Li, K., Kong, Y., Zhang, M., Xie, F., Liu, P., & Xu, S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.182 · Cited by 34
Synapse pathology and translational applications for schizophrenia
Hayashi‐Takagi, A. (2016) · Neuroscience Research · doi:10.1016/j.neures.2016.09.001 · Cited by 32
Collo, G., Mucci, A., Giordano, G. M., Pich, E. M., & Galderisi, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00632 · Cited by 35
Modeling developmental neuropsychiatric disorders with iPSC technology: challenges and opportunities
Young‐Pearse, T. L., & Morrow, E. M. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.10.006 · Cited by 35
Mental health dished up—the use of iPSC models in neuropsychiatric research
McNeill, R. V., Ziegler, G. C., Radtke, F., Nieberler, M., Lesch, K., & Kittel‐Schneider, S. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02197-9 · Cited by 32
Ho, M., Zhang, C., Moon, I., Zhu, X., Coombes, B. J., Biernacka, J. M., Skime, M. K., Oesterle, T., Karpyak, V. M., Schmidt, K., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01837-8 · Cited by 33
Self-citationPolit, L. D., Eidhof, I., McNeill, R. V., Warre-Cornish, K. M., Ohki, C. M. Y., Walter, N. M., Sala, C., Verpelli, C., Radtke, F., Galderisi, S., et al. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.101125 · Cited by 32
Caldérari, S., Ria, M., Gérard, C., Nogueira, T. C., Villate, O., Collins, S. C., Neil, H., Gervasi, N., Hue, C., Suárez-Zamorano, N., et al. (2017) · Genomics · doi:10.1016/j.ygeno.2017.09.001 · Cited by 32
Modeling Neurovascular Disorders and Therapeutic Outcomes with Human-Induced Pluripotent Stem Cells
Bosworth, A. M., Faley, S. L., Bellan, L. M., & Lippmann, E. S. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00087 · Cited by 32
Hatakeyama, H., & Goto, Y. (2016) · Stem Cells · doi:10.1002/stem.2292 · Cited by 31
Wang, H., Hu, L., Liu, C., Su, Z., Wang, L., Pan, G., Guo, Y., & He, J. (2016) · Scientific Reports · doi:10.1038/srep20033 · Cited by 30
Novel schizophrenia risk factor pathways regulate FEZ1 to advance oligodendroglia development
Chen, X., Ku, L., Mei, R., Liu, G., Xu, C., Wen, Z., Zhao, X., Wang, F., Xiao, L., & Feng, Y. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0028-z · Cited by 32
Self-citationStudying the Brain in a Dish: 3D Cell Culture Models of Human Brain Development and Disease
Brown, J. R., Quadrato, G., & Arlotta, P. (2018) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2018.03.002 · Cited by 32
Balan, S., Toyoshima, M., & Yoshikawa, T. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.021 · Cited by 31
Corrêa-Velloso, J. C., Gonçalves, M. C., Naaldijk, Y., Oliveira‐Giacomelli, Á., Pillat, M. M., & Ulrich, H. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.033 · Cited by 31
Hong, Y., Yang, Q., Song, H., & Ming, G. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01990-8 · Cited by 34
Self-citationDevelopmental convergence and divergence in human stem cell models of autism
Gordon, A., Yoon, S., Bicks, L. K., Martín, J. M., Pintacuda, G., Arteaga, S. A., Wamsley, B., Guo, Q., Elahi, L. S., Dolmetsch, R. E., et al. (2026) · Nature · doi:10.1038/s41586-025-10047-5 · Cited by 42
Metadata
- Authors
- Wen, Z., Nguyen, H. N., Guo, Z., Lalli, M. A., Wang, X., Su, Y., Kim, N.-S., Yoon, K.-J., Shin, J., Zhang, C., Makri, G., Nauen, D., Yu, H., Guzman, E., Chiang, C.-H., Yoritomo, N., Kaibuchi, K., Zou, J., Christian, K. M., Cheng, L., Ross, C. A., Margolis, R. L., Chen, G., Kosik, K. S., Song, H., & Ming, G.-L.
- Affiliations
- Johns Hopkins University (US)
- Pennsylvania State University (US)
- University of California, Santa Barbara (US)
- Nagoya University (JP)
- Corresponding author
- Ming, Guo-li
- ORCID
- Wen, Zhexing
- Nguyen, Ha Nam
- Guo, Ziyuan
- Lalli, Matthew A.
- Wang, Xinyuan
- Su, Yijing
- Kim, Nam-Shik
- Yoon, Ki-Jun
- Shin, Jaehoon
- Zhang, Ce
- Makri, Georgia
- Nauen, David
- Yu, Huimei
- Guzman, Elmer
- Yoritomo, Nadine
- Kaibuchi, Kozo
- Zou, Jizhong
- Christian, Kimberly M.
- Cheng, Linzhao
- Ross, Christopher A.
- Margolis, Russell L.
- Chen, Gong
- Kosik, Kenneth S.
- Song, Hongjun
- Ming, Guo-li
- Venue
- Nature
- Published
- 2014-08-17
- Volume
- 515
- Issue
- 7527
- Pages
- 414-418
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4501856
- OpenAlex
- W1968461255
- Cited by
- 549
- References
- 40
- Citations by year
- 2026: 29 · 2025: 31 · 2024: 26 · 2023: 34 · 2022: 38 · 2021: 50 · 2020: 53 · 2019: 46 · 2018: 58 · 2017: 58 · 2016: 60 · 2015: 62 · 2014: 4
- FWCI
- 25.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute on Aging (AG045656, R01AG045656, R01AG024984)
- National Institute of Mental Health (R01MH083911, R21MH087874, R33MH087874, R21MH092740, MH087874, MH102978, R01MH105128, F31MH102978)
- National Institute of General Medical Sciences (T32GM008752)
- National Institute of Neurological Disorders and Stroke (NS 048271, R01NS047344, NS 047344, R01NS048271, R37NS047344, R56NS047344)
- National Institute of Environmental Health Sciences (R21ES021957)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- DISC1, schizophrenia, induced pluripotent stem cells, synaptic dysfunction, synaptic vesicle release, transcriptional dysregulation, forebrain neurons, isogenic cell lines, genome editing, mental illness, brain development
- MeSH terms
- Animals, Mental Disorders, Cell Differentiation, Fibroblasts, Glutamine, Humans, Male, Mutation, Nerve Tissue Proteins, Neurons, Pedigree, Protein Binding, Synapses, Prosencephalon, Presynaptic Terminals, Mutant Proteins, Mice, Induced Pluripotent Stem Cells, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review